Literature DB >> 2999365

Characterization of tumour cells in malignant fibrous histiocytomas and other soft tissue tumours in comparison with malignant histiocytes. I. Immunohistochemical study on paraffin sections.

P J Roholl, J Kleyne, H Elbers, M C Van der Vegt, C Albus-Lutter, J A Van Unnik.   

Abstract

We have studied the possible origin of histiocytic cells, present in fibrous histiocytomas (MFH) by using immunohistochemistry to demonstrate lysozyme, alpha 1-antitrypsin, alpha 1-antichymotrypsin and receptors for peanut and soy bean agglutinin in tumour cells of MFH compared with their presence in tumour cells of malignant histiocytosis (MH) ('true' histiocytic lymphoma, 'true' histiocytic sarcoma). We included in this study a number of other soft tissue tumours (STT). Lysozyme was detected in half of the cases of malignant histiocytosis (n = 16) but in only two out of 77 MFH. alpha 1-Antitrypsin and alpha 1-antichymotrypsin usually occurred together although the latter was seen in more cases. Both markers were present in majority of cases of MH whereas they were detected in a minority of cases of MFH. MFH cases of the storiform subtype were less frequently stained than the pleomorphic or giant cell subtypes. Receptors for peanut or soy bean agglutinin were detected in nearly all MH cases, whereas their presence was only detected in a small number of MFH. Lysozyme was not detectable in other STT. alpha 1-Antitrypsin and alpha 1-antichymotrypsin were uncommonly present in other STT, except in osteosarcoma and rhabdomyosarcoma. These markers therefore have a limited value as indicators of a possible histiocytic origin of MFH. Lectins showed weak affinity for other STT. In accordance with others, we therefore conclude that the progenitor cell of MFH has to be sought within the undifferentiated mesenchymal cells and that histiocytes themselves probably do not give rise to MFH.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2999365     DOI: 10.1002/path.1711470203

Source DB:  PubMed          Journal:  J Pathol        ISSN: 0022-3417            Impact factor:   7.996


  8 in total

1.  Malignant fibrous histiocytoma.

Authors:  J R Salisbury
Journal:  Postgrad Med J       Date:  1989-12       Impact factor: 2.401

2.  Case report 444. Subperiosteal malignant fibrous histocytoma (MFH) of thigh, with involvement of femur.

Authors:  H B Kemp; P D Byers
Journal:  Skeletal Radiol       Date:  1987       Impact factor: 2.199

3.  Malignant fibrous histiocytoma. Evidence of perivascular mesenchymal cell origin immunocytochemical studies with monoclonal anti-MFH antibodies.

Authors:  H Iwasaki; T Isayama; H Johzaki; M Kikuchi
Journal:  Am J Pathol       Date:  1987-09       Impact factor: 4.307

4.  Histiocytic differentiation in benign and malignant bone tumors.

Authors:  A Meyer; T Steinmeier; T Löning; H J Radzun; G Delling
Journal:  J Cancer Res Clin Oncol       Date:  1988       Impact factor: 4.553

5.  Osteoclast-like giant cell tumour of the gallbladder.

Authors:  M Ito; C T Hsu; S Naito; T Matsuo; S Onizuka; I Sekine; H Fujii; Y Matsuoka
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1992

6.  Gliosarcoma: an immunohistochemical study.

Authors:  J W Grant; P V Steart; A Aguzzi; D B Jones; P J Gallagher
Journal:  Acta Neuropathol       Date:  1989       Impact factor: 17.088

7.  Malignant fibrous histiocytoma: similarities to the "fibrohistiocytoid cells" in chronic inflammation.

Authors:  Y Imai; M Yamakawa; T Sato; A Suda
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1989

8.  Does the pleomorphic xanthoastrocytoma exist? Problems in the application of immunological techniques to the classification of brain tumors.

Authors:  W Paulus; J Peiffer
Journal:  Acta Neuropathol       Date:  1988       Impact factor: 17.088

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.